P. Raptopoulos

547 total citations
7 papers, 460 citations indexed

About

P. Raptopoulos is a scholar working on Pharmacology, Cognitive Neuroscience and Experimental and Cognitive Psychology. According to data from OpenAlex, P. Raptopoulos has authored 7 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Cognitive Neuroscience and 3 papers in Experimental and Cognitive Psychology. Recurrent topics in P. Raptopoulos's work include Treatment of Major Depression (3 papers), Functional Brain Connectivity Studies (2 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers). P. Raptopoulos is often cited by papers focused on Treatment of Major Depression (3 papers), Functional Brain Connectivity Studies (2 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers). P. Raptopoulos collaborates with scholars based in United Kingdom, Gibraltar and South Africa. P. Raptopoulos's co-authors include Nikiforos V. Angelopoulos, Murray W. Johns, Brian W. Ellis, Robert G. Priest, Richard Lancaster, G. R. McClelland, G Beaumont, Sarah J. Dunstan, Alan Cooper and John Pomeroy and has published in prestigious journals such as Journal of Affective Disorders, SLEEP and Psychopharmacology.

In The Last Decade

P. Raptopoulos

7 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Raptopoulos United Kingdom 7 216 211 92 89 51 7 460
A. C. Parrott United Kingdom 9 333 1.5× 305 1.4× 107 1.2× 93 1.0× 55 1.1× 10 624
Roberto A. Dominguez United States 10 199 0.9× 171 0.8× 61 0.7× 126 1.4× 60 1.2× 20 480
P. Tyrer United Kingdom 8 148 0.7× 85 0.4× 68 0.7× 94 1.1× 61 1.2× 18 403
H. Kuhs Germany 13 231 1.1× 136 0.6× 139 1.5× 175 2.0× 37 0.7× 31 509
Mark Zetin United States 14 161 0.7× 213 1.0× 90 1.0× 257 2.9× 51 1.0× 33 706
Ben Zimmer United States 11 178 0.8× 261 1.2× 99 1.1× 187 2.1× 35 0.7× 24 564
Michael Müeck‐Weymann Germany 15 126 0.6× 97 0.5× 77 0.8× 80 0.9× 29 0.6× 25 691
Ann B. McEachran United States 18 389 1.8× 362 1.7× 196 2.1× 186 2.1× 33 0.6× 28 741
Michael Thase United States 7 196 0.9× 161 0.8× 103 1.1× 87 1.0× 18 0.4× 8 383
Cláudia Hara Brazil 12 140 0.6× 99 0.5× 146 1.6× 180 2.0× 38 0.7× 27 481

Countries citing papers authored by P. Raptopoulos

Since Specialization
Citations

This map shows the geographic impact of P. Raptopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Raptopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Raptopoulos more than expected).

Fields of papers citing papers by P. Raptopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Raptopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Raptopoulos. The network helps show where P. Raptopoulos may publish in the future.

Co-authorship network of co-authors of P. Raptopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of P. Raptopoulos. A scholar is included among the top collaborators of P. Raptopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Raptopoulos. P. Raptopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Raptopoulos, P., et al.. (1989). The clinical pharmacology of paroxetine in healthy subjects. Acta Psychiatrica Scandinavica. 80(S350). 46–48. 15 indexed citations
2.
McClelland, G. R., et al.. (1989). The psychomotor effects of paroxetine alone and in combination with haloperidol, amylobarbitone, oxazepam, or alcohol. Acta Psychiatrica Scandinavica. 80(S350). 53–55. 19 indexed citations
3.
McClelland, G. R., et al.. (1989). The effect of paroxetine on the quantitative EEG. Acta Psychiatrica Scandinavica. 80(S350). 50–52. 46 indexed citations
4.
McClelland, G. R. & P. Raptopoulos. (1984). EEG and blood level of the potential antidepressant paroxetine after a single oral dose to normal volunteers. Psychopharmacology. 83(4). 327–329. 35 indexed citations
5.
Cooper, Alan, Sarah J. Dunstan, John Pomeroy, et al.. (1982). Does lofepramine have fewer side effects than amitriptyline?. Journal of Affective Disorders. 4(4). 355–363. 18 indexed citations
6.
Ellis, Brian W., Murray W. Johns, Richard Lancaster, et al.. (1981). The St. Mary's Hospital Sleep Questionnaire: A Study of Reliability. SLEEP. 4(1). 93–97. 318 indexed citations
7.
Beaumont, G, et al.. (1980). Suicide, attempted suicide and antidepressant drugs.. PubMed. 8 Suppl 3. 8–13. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026